Mucin 4 is a cellular biomarker of necrotizing bronchiolitis in influenza A virus infection.
暂无分享,去创建一个
Tavis K. Anderson | T. Anderson | Samantha J. Hau | Amy L. Vincent Baker | Garrett M. Janzen | B. Arruda | Rachel A Kanefsky | Samantha Hau
[1] Gregg A. Duncan,et al. Membrane-Tethered Mucin 1 Is Stimulated by Interferon and Virus Infection in Multiple Cell Types and Inhibits Influenza A Virus Infection in Human Airway Epithelium , 2022, mBio.
[2] N. Bertho,et al. The pig as a medical model for acquired respiratory diseases and dysfunctions: An immunological perspective. , 2021, Molecular immunology.
[3] T. Käser. Swine as biomedical animal model for T-cell research-Success and potential for transmittable and non-transmittable human diseases. , 2021, Molecular immunology.
[4] R. Main,et al. Visualization and application of disease diagnosis codes for population health management using porcine diseases as a model , 2021, Journal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc.
[5] Gregg A. Duncan,et al. Influenza A virus diffusion through mucus gel networks , 2020, Communications Biology.
[6] S. Boxer,et al. Membrane-tethered mucin-like polypeptides sterically inhibit binding and slow fusion kinetics of influenza A virus , 2019, Proceedings of the National Academy of Sciences.
[7] Rasna W Walia,et al. ISU FLUture: a veterinary diagnostic laboratory web-based platform to monitor the temporal genetic patterns of Influenza A virus in swine , 2018, BMC Bioinformatics.
[8] Ivo M Foppa,et al. Annual estimates of the burden of seasonal influenza in the United States: A tool for strengthening influenza surveillance and preparedness , 2018, Influenza and other respiratory viruses.
[9] Katharina Ribbeck,et al. The particle in the spider's web: transport through biological hydrogels. , 2017, Nanoscale.
[10] L. Ostrowski,et al. Cilia and Mucociliary Clearance. , 2017, Cold Spring Harbor perspectives in biology.
[11] L. Brown,et al. The cell surface mucin MUC1 limits the severity of influenza A virus infection , 2017, Mucosal Immunology.
[12] R. Prather,et al. Swine models, genomic tools and services to enhance our understanding of human health and diseases , 2017, Lab Animal.
[13] R. Webster,et al. The Interaction between Respiratory Pathogens and Mucus. , 2016, Cell host & microbe.
[14] Akiko Iwasaki,et al. Innate immunity to influenza virus infection , 2014, Nature Reviews Immunology.
[15] P. Taylor,et al. Interleukin‐6 limits influenza‐induced inflammation and protects against fatal lung pathology , 2013, European journal of immunology.
[16] Oliver Lieleg,et al. Mucin biopolymers as broad-spectrum antiviral agents. , 2012, Biomacromolecules.
[17] F. Clubb,et al. Swine as Models in Biomedical Research and Toxicology Testing , 2012, Veterinary pathology.
[18] J. Widdicombe,et al. Cystic fibrosis and the relationship between mucin and chloride secretion by cultures of human airway gland mucous cells. , 2011, American journal of physiology. Lung cellular and molecular physiology.
[19] J. Fahy,et al. Airway mucus function and dysfunction. , 2010, The New England journal of medicine.
[20] Jeannette Guarner,et al. Comparison of the pathology caused by H1N1, H5N1, and H3N2 influenza viruses. , 2009, Archives of medical research.
[21] Yan Zhang,et al. Characterization of an influenza A virus isolated from pigs during an outbreak of respiratory disease in swine and people during a county fair in the United States. , 2009, Veterinary microbiology.
[22] S. Batra,et al. Structure, evolution, and biology of the MUC4 mucin , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[23] V. Korolik,et al. Mucins in the mucosal barrier to infection , 2008, Mucosal Immunology.
[24] M. McGuckin,et al. Structure and function of the polymeric mucins in airways mucus. , 2008, Annual review of physiology.
[25] S. Gendler,et al. Structure and function of the cell surface (tethered) mucins. , 2008, Annual review of physiology.
[26] C. A. Carraway,et al. Sequestration and Segregation of Receptor Kinases in Epithelial Cells: Implications for ErbB2 Oncogenesis , 2007, Science's STKE.
[27] P. Singh,et al. Cell surface-associated mucins in signal transduction. , 2006, Trends in cell biology.
[28] E. Thacker,et al. The immune response and maternal antibody interference to a heterologous H1N1 swine influenza virus infection following vaccination. , 2006, Veterinary immunology and immunopathology.
[29] S. Brody,et al. Influenza Virus Receptor Specificity and Cell Tropism in Mouse and Human Airway Epithelial Cells , 2006, Journal of Virology.
[30] Cary Lai,et al. The Mucin Muc4 Potentiates Neuregulin Signaling by Increasing the Cell-surface Populations of ErbB2 and ErbB3* , 2006, Journal of Biological Chemistry.
[31] Erik K. Malm,et al. A Human Protein Atlas for Normal and Cancer Tissues Based on Antibody Proteomics* , 2005, Molecular & Cellular Proteomics.
[32] K. Carraway,et al. Presence of MUC4 in human milk and at the luminal surfaces of blood vessels , 2005, Journal of cellular physiology.
[33] G. Whittaker,et al. Influenza virus entry and infection require host cell N-linked glycoprotein , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[34] M. V. von Herrath,et al. Molecular and cellular control of T1/T2 immunity at the interface between antimicrobial defense and immune pathology. , 2004, DNA and cell biology.
[35] M. Knowles,et al. Mucus clearance as a primary innate defense mechanism for mammalian airways. , 2002, The Journal of clinical investigation.
[36] C. A. Carraway,et al. Muc4/Sialomucin Complex in the Mammary Gland and Breast Cancer , 2001, Journal of Mammary Gland Biology and Neoplasia.
[37] G. Apodaca,et al. Clathrin-mediated endocytosis of MUC1 is modulated by its glycosylation state. , 2000, Molecular biology of the cell.
[38] N. Moniaux,et al. Complete sequence of the human mucin MUC4: a putative cell membrane-associated mucin. , 1999, The Biochemical journal.
[39] C. A. Carraway,et al. An Intramembrane Modulator of the ErbB2 Receptor Tyrosine Kinase That Potentiates Neuregulin Signaling* , 1999, The Journal of Biological Chemistry.
[40] A. Wanner,et al. Mucociliary clearance in the airways. , 1996, American journal of respiratory and critical care medicine.
[41] P. Halbur,et al. Comparison of the Pathogenicity of Two US Porcine Reproductive and Respiratory Syndrome Virus Isolates with that of the Lelystad Virus , 1995, Veterinary pathology.
[42] C. A. Carraway,et al. Tumor sialomucin complexes as tumor antigens and modulators of cellular interactions and proliferation. , 1992, Journal of cell science.
[43] K. Carraway,et al. Molecular cloning of the transmembrane component of the 13762 mammary adenocarcinoma sialomucin complex. A new member of the epidermal growth factor superfamily. , 1992, The Journal of biological chemistry.
[44] J. Shelhamer,et al. Human respiratory mucus. , 1984, The American review of respiratory disease.
[45] L. Reed,et al. A SIMPLE METHOD OF ESTIMATING FIFTY PER CENT ENDPOINTS , 1938 .
[46] J. Voynow,et al. Respiratory tract mucin genes and mucin glycoproteins in health and disease. , 2006, Physiological reviews.
[47] C. A. Carraway,et al. Multiple facets of sialomucin complex/MUC4, a membrane mucin and erbb2 ligand, in tumors and tissues (Y2K update). , 2000, Frontiers in bioscience : a journal and virtual library.